Syros Pharmaceuticals Obtains $53,149,996 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0546dddc-4442-4227-9a82-f46086eb06d9 - Date
10/27/2014 - Company Name
Syros Pharmaceuticals - Mailing Address
480 Arsenal Street Watertown, MA 02472 USA - Company Description
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities. - Website
http://www.syros.com - Transaction Type
Venture Equity - Transaction Amount
$53,149,996 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
